Resources Library by ANA

Information is power

This paper traces the evolution of the marketing research function within what is now Knoll Pharmaceuticals and what was, until April 1995 Boots Pharmaceuticals. It draws on relevant experiences over the last sixteen years to illustrate the central...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Catherine Ayland, Anne Marshall

June 15, 1997

From market research to marketing research and development

The world’s top ten pharmaceutical companies continue to reorient their strategies toward greater focus on core therapeutic segments and continuous improvement of efficiency in the development and marketing of their new chemical entities (NCE)....

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Kenneth G. Watson, Andre Boer

June 15, 1997

Is there life after death?

When a company is developing several important new compounds and one is facing challenges in formulation development, it is important to establish whether the potential for the product with an alternative formulation would be viable in sales terms....

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Alan J. Bowditch, Lorna Tuersley

June 15, 1997

Conjoint analysis

This paper begins by discussing the components of a conjoint paradigm and the alternatives within each. This is done to introduce a discussion of three issues: the concept of a “best” paradigm, the use of preference share as a predictor of...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Author: Roger Brice

June 15, 1997

The perception of new clinical entities

The most crucial time for close co-operation between clinical research and marketing research is during phase II and early phase III of clinical development. In these phases of development it is necessary to compare the new substance with similar...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Raf De Wilde, Barbel Matiaske

June 15, 1997

When marketing is a matter of life and death

The AIDS epidemic does not only struggle for supremacy within the bodies of those who have the disease. Its power and its mythology have also entered the psyches of virtually everyone, at least in the United States. The virulence of the disease...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Hazel Kahan, Dave Mulryan

June 15, 1997

From evolution to revolution

Competitive advantage can rest with getting the right information to the right people at the right time allowing them to take the right action. Information providers, and in particular market researchers, have a key role to play in this process. We...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Author: L. J. M. MacMillan

Company: GSK

June 15, 1997

Pharmaceutical strategy through innovative market research

This market research effort will help you to do the things needed to make the right decisions. As a result, your work will be simplified, and in alignment with your customers needs and profitability goals of your company.

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Author: William V. Lawson

June 15, 1997

Heat, misery and mosquitoes

The paper describes a multi-country study carried out on behalf of SmithKline Beecham International by Complete Market Research. The aim of the study was to explore the anti-malarial market in several developing countries, and to identify potential...

Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future

Authors: Carole Abbotts, Georgina Butcher

Company: GSK

June 15, 1997